• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Actuate Receives EMA Orphan Status For Elraglusib In Cancer

    GLOBENEWSWIRE

    Actuate Therapeutics Announces Interim Data for Elraglusib

    GLOBENEWSWIRE

    Actuate Gets FDA Rare Pediatric Designation for Elraglusib

    GLOBENEWSWIRE

    Actuate Reports Elraglusib Mechanism In Scientific Reports

    GLOBENEWSWIRE

    Actuate Announces Elraglusib Data Presentation At AACR

    GLOBENEWSWIRE

    Actuate Gets FDA Orphan Drug Designation For Elraglusib In Sarcomas

    GLOBENEWSWIRE

    Actuate Therapeutics Obtains Complete Responses

    GLOBENEWSWIRE

    Actuate To Present At H.C. Wainwright Investment Conference

    GLOBENEWSWIRE

    Actuate unveils modest $50M IPO to fund cancer drug trials

    FIERCE BIOTECH

    Clinical-stage cancer biotech Actuate latest to eye summer IPO

    FIERCE BIOTECH

    Actuate Therapeutics Receives FDA Orphan Drug Designation for Elraglusib

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.